Hypertrophic cardiomyopathy: genetic factors and their role instratifying the risk for associated outcomes

Authors

  • Diogo Coelho TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.
  • Osvaldo Lourenço TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal. Clínica Multiperfil – Medical-Surgical Research Center of Angola, Luanda, Angola.

DOI:

https://doi.org/10.51126/revsalus.v4iSup.393

Keywords:

genetic signature, mutations, hypertrophic cardiomyopathy, genetic variability, risk stratification

Downloads

Download data is not yet available.

Downloads

Published

2022-04-06

Conference Proceedings Volume

Vol. 4 No. Sup (2022): Suplemento da RevSALUS - Revista Científica Internacional da RACS

Section

Posters

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:
Share — copy and redistribute the material in any medium or format;
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

How to Cite

Hypertrophic cardiomyopathy: genetic factors and their role instratifying the risk for associated outcomes. (2022). RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone, 4(Sup), 161. https://doi.org/10.51126/revsalus.v4iSup.393